Evelo Biosciences, Inc., a clinical-stage biotechnology company, focuses on discovering and developing oral medicines that act on immune cells in the small intestine with systemic effects. It is developing EDP1815, a whole-microbe product candidate, which has completed a Phase 2 trial for the treatm... Evelo Biosciences, Inc., a clinical-stage biotechnology company, focuses on discovering and developing oral medicines that act on immune cells in the small intestine with systemic effects. It is developing EDP1815, a whole-microbe product candidate, which has completed a Phase 2 trial for the treatment of psoriasis . The company is also developing EDP1867, a non-live pharmaceutical preparation for single strain of Veillonella parvula, which is in Phase 1b clinical trial; EDP2939, an investigational oral biologic for the potential treatment of inflammatory diseases; and EDP1908, a product candidate for oncology. Evelo Biosciences, Inc. was incorporated in 2014 and is headquartered in Cambridge, Massachusetts. 詳細を表示
| 期間 † | 前日比 | 前日比 % | 始値 | 高値 | 安値 | 平均出来高 | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.0002 | -66.6666666667 | 0.0003 | 0.0003 | 1.0E-6 | 6700 | 0.0003 | CS |
| 4 | 9.9E-5 | 9900 | 1.0E-6 | 0.0003 | 1.0E-6 | 3560 | 0.00028236 | CS |
| 12 | 0 | 0 | 0.0001 | 0.0003 | 1.0E-6 | 2014 | 0.00014501 | CS |
| 26 | 0 | 0 | 0.0001 | 0.0005 | 1.0E-6 | 2939 | 0.00023082 | CS |
| 52 | -0.0004 | -80 | 0.0005 | 0.0006 | 1.0E-6 | 3914 | 0.00039698 | CS |
| 156 | -0.1604 | -99.937694704 | 0.1605 | 0.2475 | 1.0E-6 | 33230 | 0.04856964 | CS |
| 260 | -0.1604 | -99.937694704 | 0.1605 | 0.2475 | 1.0E-6 | 33230 | 0.04856964 | CS |
TRUSTUNITS1000000
6分前
TRUSTUNITS1000000
6分前
Talisman33
8分前
sissyjane1
11分前
yadotn
11分前
JerryCampbell
12分前
shadolane
12分前
janetcanada
12分前
jimr1717
14分前
Koog
19分前
Achilles deFlandres
21分前
jimr1717
21分前
VapeGod3000
23分前
jimr1717
23分前
jimr1717
24分前
The-Shadow
24分前
meixatech
25分前
The-Shadow
31分前
trusttheman
31分前
bobby1151
32分前
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約
すでにアカウントをお持ちですか? サインイン
アカウントをお持ちでないですか? 登録
登録することで、ADVFN の 利用規約 を読み、理解し、同意したこと、および私が個人投資家であることを確認します。